| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US6828339 | SYNTHON PHARMS | Amlodipine salt forms and processes for preparing them |
Nov, 2022
(10 months ago) | |
Amlodipine Besylate is owned by Synthon Pharms.
Amlodipine Besylate contains Amlodipine Besylate.
Amlodipine Besylate has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Amlodipine Besylate are:
- US6828339
Amlodipine Besylate was authorised for market use on 27 September, 2007.
Amlodipine Besylate is available in tablet, orally disintegrating;oral dosage forms.
The generics of Amlodipine Besylate are possible to be released after 20 November, 2022.
Drugs and Companies using AMLODIPINE BESYLATE ingredient
Market Authorisation Date: 27 September, 2007
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
AMLODIPINE BESYLATE family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic